Twist Bioscience (TWST) Short-term Investments (2018 - 2026)

Twist Bioscience has disclosed Short-term Investments across 9 years of filings, most recently posting $49.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 4.93% year-over-year to $49.0 million; the TTM figure through Mar 2026 stood at $49.0 million (up 4.93% YoY), while the FY2025 annual figure was $49.4 million, down 1.39% from the prior year.
• Short-term Investments fell to $49.0 million in Q1 2026, from $49.4 million in the prior quarter.
• Over the last five years, Short-term Investments for TWST reached as high as $166.2 million in Q1 2022 and fell as low as $44.9 million in Q4 2023.
• The 5-year median for Short-term Investments is $49.9 million (2023), against an average of $72.1 million.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 949.37% — and 2023, when it plunged 67.17%.
• A 5-year view of Short-term Investments shows it stood at $122.0 million in 2022, then slumped by 63.23% to $44.9 million in 2023, then rose by 10.14% to $49.4 million in 2024, then decreased by 0.13% to $49.4 million in 2025, then slipped by 0.72% to $49.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $49.0 million, $49.4 million, and $49.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.